Document Detail


Metabolic and inflammatory faecal markers in collagenous colitis.
MedLine Citation:
PMID:  17556903     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: To evaluate the excretion of the inflammatory and metabolic faecal markers calprotectin, lactoferrin, and short-chain fatty acids in symptomatic and quiescent collagenous colitis. METHODS: Faecal samples from 21 patients with active collagenous colitis, 12 patients retested in remission, and 13 controls were analysed. Calprotectin was determined using an enzyme-linked immunosorbent assay. Lactoferrin was estimated by a latex agglutination test. Short-chain fatty acids were determined by steam distillation followed by gas-liquid chromatography. RESULTS: Calprotectin was increased in patients with active collagenous colitis [80 microg/g (6.25-1899)] (median and range) compared with patients with quiescent collagenous colitis [26 microg/g (6.25-340)], P=0.025 and controls [6.25 microg/g (6.25-99)], P=0.002. Eight patients (38%) with active collagenous colitis had normal levels of calprotectin. Lactoferrin was detected in one patient only. Concentrations of total short-chain fatty acids did not differ in patients with active collagenous colitis compared with quiescent collagenous colitis or controls (P=0.75), whereas concentrations of the branched-chain fatty acids were decreased in patients with active collagenous colitis versus controls (P<0.005). In-vitro incubations demonstrated increased ratios of acetate in patients with active and quiescent collagenous colitis compared with controls (P<0.05), with a corresponding decrease in branched-chain fatty acids ratios (P<0.05). CONCLUSION: Faecal calprotectin was increased in collagenous colitis; however, increased excretion was not a universal finding limiting the use of calprotectin as an inflammatory marker in collagenous colitis. Faecal lactoferrin was almost undetectable. Luminal fermentative conditions are altered in collagenous colitis. Fermentative alterations could be secondary to changes in substrate availability and intestinal transit time.
Authors:
Signe Wildt; Inge Nordgaard-Lassen; Flemming Bendtsen; Jüri J Rumessen
Related Documents :
9696903 - Understanding dressings.
4028043 - N.m.r. studies of the disulphated disaccharide obtained by degradation of bovine lung h...
2254453 - Carbohydrate malabsorption. its measurement and its contribution to diarrhea.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of gastroenterology & hepatology     Volume:  19     ISSN:  0954-691X     ISO Abbreviation:  Eur J Gastroenterol Hepatol     Publication Date:  2007 Jul 
Date Detail:
Created Date:  2007-06-08     Completed Date:  2007-09-04     Revised Date:  2009-10-16    
Medline Journal Info:
Nlm Unique ID:  9000874     Medline TA:  Eur J Gastroenterol Hepatol     Country:  England    
Other Details:
Languages:  eng     Pagination:  567-74     Citation Subset:  IM    
Affiliation:
Department of Medical Gastroenterology, Hvidovre Hospital, University of Copenhagen, Denmark. siw@dadlnet.dk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Biological Markers / metabolism
Colitis, Collagenous / metabolism*
Fatty Acids, Volatile / metabolism
Feces / chemistry*
Female
Humans
Inflammation Mediators / metabolism*
Lactoferrin / metabolism
Leukocyte L1 Antigen Complex / metabolism
Male
Middle Aged
Prospective Studies
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Fatty Acids, Volatile; 0/Inflammation Mediators; 0/Lactoferrin; 0/Leukocyte L1 Antigen Complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-ind...
Next Document:  Temperature-controlled radiofrequency energy (SECCA) to the anal canal for the treatment of faecal i...